Dr. Chemello completed his PhD at the University of La Réunion in 2022 and is currently an early career researcher at the University of New South Wales. His research takes a multidisciplinary approach, combining metabolic and immunological perspectives to advance the prevention and treatment of type 1 diabetes. His work focuses on developing therapeutic strategies that preserve pancreatic beta cells, enhance their function, and promote their regeneration.